Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening
NCT ID: NCT06527456
Last Updated: 2025-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
11200 participants
INTERVENTIONAL
2025-12-31
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Since 2018, a national Organized Cervical Cancer Screening program (DOCCU) has been set up and concerns all asymptomatic women aged 25 to 65.
This program, managed by the Regional Cancer Screening Coordination Centers (CRCDC), invites women who have not taken a sample within the recommended time frame to consult for screening. However, only 59% of patients participated.
The intervention of the general practitioner, an essential player in prevention, could allow for better awareness.
The objective of the INDIGO study is to evaluate the effectiveness of the intervention of a general practitioner on the participation rate in the DOCCU of patients who are not up to date with their screening.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Access to Cervical Cancer Screening
NCT03118258
Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner
NCT02749110
A Proximity-incentive Strategy for Cervical Cancer Screening
NCT04716127
Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)
NCT07226037
Combined Incentive Actions, Focusing on Primary Care, to Improve Cervical Cancer Screening in Women Residing in Socio-economically Disadvantaged and Untracked Geographical Areas: a Hybrid Efficacy and Implementation Trial
NCT04312178
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
If they are in the "intervention" group, they or one of the professionals in their team will contact the patient (phone call, SMS, email, etc.), to encourage her to make an appointment to carry out the screening. Contact arrangements are left to the discretion of each general practitioner..
If they are in the "Usual practice" group, they will use their usual practices to encourage screening.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
usual practice
the doctor will use their usual practices to encourage screening.
No interventions assigned to this group
Intervention
the general practitioner or one of the professionals on their team will contact the patient (phone call, SMS, email, etc.), to encourage them to make an appointment to carry out the screening
participation of the general practitioner
participation of the general practitioner in encouraging cervical cancer screening
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
participation of the general practitioner
participation of the general practitioner in encouraging cervical cancer screening
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eligible for DOCCU (not hysterectomized, not followed for a pre-cancerous or cancerous lesion of the cervix)
* Having declared the investigating general practitioner as a treating physician (MT) and whose MT practices in the territory of a CPTS in the UPEC area
* Affiliate to a social security scheme or beneficiary of such a scheme
Exclusion Criteria
* Patient excluded from organized screening (cervical cancer, hysterectomy).
* Patient's opposition to participating in the study
25 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Intercommunal Creteil
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INDIGO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.